MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

02 Nov 2021 Evaluate
An increase of about 8605.71% to Rs. 60.94 millions in the total revenue was observed for the quarter ended September 2021. The total revenue was pegged at Rs. 0.70 millions during the similar quarter previous year.The Net Profit of the company vaulted to 581.25% to Rs. 2.18  millions from Rs. 0.32 millions in the previous quarter.Operating profit surged to 6.39 millions from the corresponding previous quarter of 0.59 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 60.94 0.70 8605.71 145.39 0.70 20670.00 119.91 0.00 0.00
Other Income 1.94 0.21 823.81 3.20 1.22 162.30 4.60 4.30 6.98
PBIDT 6.39 0.59 983.05 13.14 1.15 1042.61 9.83 2.61 276.63
Interest 1.86 0.06 3000.00 2.32 0.12 1833.33 0.88 0.68 29.41
PBDT 4.53 0.53 754.72 10.82 1.03 950.49 8.95 1.93 363.73
Depreciation 1.61 0.15 973.33 2.54 0.30 746.67 0.62 0.62 0.00
PBT 2.92 0.38 668.42 8.28 0.73 1034.25 8.33 1.31 535.88
TAX 0.74 0.06 1133.33 2.09 0.15 1293.33 2.18 0.02 10800.00
Deferred Tax 0.53 0.00 0.00 1.30 -0.01 -13100.00 -0.03 -0.20 -85.00
PAT 2.18 0.32 581.25 6.19 0.58 967.24 6.15 1.29 376.74
Equity 83.16 38.20 117.70 83.16 38.20 117.70 38.20 38.20 0.00
PBIDTM(%) 10.49 84.29 -87.56 9.04 164.29 -94.50 8.20 0.00 0.00
Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..